CAL
COLL icon

Capital Advisors Ltd’s Collegium Pharmaceutical COLL Stock Holding History

Capital Advisors Ltd’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$0 Hold
2
– – ﹤0.01% 1398
2026
Q1 		$0 Hold
2
– – ﹤0.01% 1402
2025
Q4 		$0 Hold
2
– – ﹤0.01% 1385
2025
Q3 		$0 Hold
2
– – ﹤0.01% 1387
2025
Q2 		$0 Buy
+2
New +$57 ﹤0.01% 1376

Other funds holding COLL

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return
AFAS
Acorn Financial Advisory Services Reston, Virginia $753M AUM 36.94% 1-Year Est. Return
SIM
SummerHaven Investment Management Stamford, Connecticut $187M AUM 70.61% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Capital Advisors Ltd's COLL Position: Q2 2026 in Review

Capital Advisors Ltd held its Collegium Pharmaceutical (COLL) position steady in Q2 2026 at 2 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1398.

Capital Advisors Ltd first reported a position in COLL in Q2 2025 and has held it in 5 quarters since. 27 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Capital Advisors Ltd held 2 shares of Collegium Pharmaceutical worth $0 as of Q2 2026.
  • Capital Advisors Ltd left its Collegium Pharmaceutical share count unchanged in Q2 2026.
  • Collegium Pharmaceutical made up ﹤0.01% of Capital Advisors Ltd's portfolio in Q2 2026, its #1398 holding.
  • Capital Advisors Ltd first reported a position in Collegium Pharmaceutical in Q2 2025 and has held it in 5 quarters since.
  • 27 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Capital Advisors Ltd's 13F filing for Q2 2026, filed 16 Jul 2026.